Company intelligence / Profile preview
MElkin Pharmaceuticals
Orleans, Centre Val De Loire, Francemelkin-pharma.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Preclinical
01
Overview
The company is pursuing preclinical development of two innovative drugs: PepFos for cancer and PepElk for depression and drug abuse. Both have been tested in various models with promising results[10].
- Therapeutic areas
- OncologyPsychiatryNeurology
- Modalities
- Synthetic cell-penetrating peptides
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on MElkin Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MElkin Pharmaceuticals.